The benefit of this therapy is that physicians can determine who may best respond. Studies have identified 6 genetic markers that are associated with iloperidone effectiveness and safety. Patients with 0 to 2 markers have approximately a 15% clinical response to iloperidone treatment. Those with 3 markers have approximately a 40% likelihood of improvement, and those with 4 markersare approximately 60% likely to improve. Almost all patients with 5 or 6 markers were shown to respond to treatment. “Even if you don’t know anything about a patient, there is still about a 48% chance of a clinical response to treatment, according to Potkin. Newer Treatments for Schizophrenia May Offer New Benefits and Drawbacks
вторник, 2 июня 2009 г.
Низкий уровень гликогена может объяснить, почему некоторые люди всегда очередь агрессивны и склонны к насилию, когда напиваются. К такому выводу пришли финские исследователи. Найден виновник агрессии алкоголиков